Scientific articles 18 Nov 2021 Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection Journal of Clinical Microbiology
Scientific articles 17 Nov 2021 Towards the elimination of visceral leishmaniasis as a public health problem in East Africa: reflections on an enhanced control strategy and a call for action The Lancet Global Health
In the media 16 Nov 2021 Malaysia hopes to become Asia’s treatment hub for hepatitis C; offering treatment at fraction of cost: Health minister Channel News Asia
Stories 10 Nov 2021 MycetOS: Harnessing the power of open source to develop treatments for a most neglected disease
In the media 6 Nov 2021 Los nuevos aliados de los fármacos contra las enfermedades desatendidas El País
In the media 4 Nov 2021 Alphabet has a new drug discovery company building on DeepMind’s AI chops STAT
Press releases 4 Nov 2021 GHIT Fund expands support for DNDi Chagas disease drug discovery programmes
Stories 29 Oct 2021 Pip Stewart on cutaneous leishmaniasis: ‘It wasn’t just the parasite that got under my skin, it was the injustice of it’
Scientific articles 28 Oct 2021 DNDI-6148: A novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis Journal of Medicinal Chemistry
Scientific articles 28 Oct 2021 Chagas disease drug discovery in Latin America – A mini review of antiparasitic agents explored between 2010 and 2021 Frontiers in Chemistry
Scientific articles 18 Nov 2021 Geographic variations in test reactivity for the serological diagnosis of Trypanosoma cruzi infection Journal of Clinical Microbiology
Scientific articles 17 Nov 2021 Towards the elimination of visceral leishmaniasis as a public health problem in East Africa: reflections on an enhanced control strategy and a call for action The Lancet Global Health
Scientific articles 28 Oct 2021 Chagas disease drug discovery in Latin America – A mini review of antiparasitic agents explored between 2010 and 2021 Frontiers in Chemistry
Scientific articles 28 Oct 2021 DNDI-6148: A novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis Journal of Medicinal Chemistry
Scientific articles 20 Oct 2021 Ravidasvir: equitable access through an alternative drug development pathway The Lancet Global Health
Scientific articles 13 Oct 2021 Onchocerciasis drug development: from preclinical models to humans Parasitology Research
Scientific articles 8 Oct 2021 Recommendations for screening and diagnosis of Chagas disease in the United States The Journal of Infectious Diseases
Scientific articles 17 Sep 2021 Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection PLOS Neglected Tropical Diseases
Scientific articles 13 Sep 2021 Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed PLOS Medicine
Scientific articles 5 Sep 2021 What China can learn from Malaysia to achieve the goal of “eliminate hepatitis C as a public health threat” by 2030 – a narrative review The Lancet Regional Health – Western Pacific
Scientific articles 20 Aug 2021 Control of visceral leishmaniasis in East Africa: fragile progress, new threats BMJ Global Health
Scientific articles 16 Aug 2021 The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform PLOS Neglected Tropical Diseases
Scientific articles 10 Aug 2021 Visceral leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans PLOS Neglected Tropical Diseases
Scientific articles 6 Aug 2021 Will science deliver needed therapeutics for COVID-19 – and how can equitable access be ensured? The British Medical Journal
Scientific articles 3 Aug 2021 Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic EClinicalMedicine
Scientific articles 26 Jul 2021 The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030 PLOS Neglected Tropical Diseases
